Traxxsson’s Cancer Guidance System™
Traxxsson uses proprietary protein biomarkers to provide non-invasive diagnostic blood tests that resolve diagnostic dilemmas in cancer. Its initial tests are focused on providing information to guide treatment decisions in breast and lung cancer.
Traxxsson provides:
Guidance to minimize invasive testing and side effects.
Guidance where currently there is no accurate way to determine whether aggressive treatment is required or not.
Guidance to improve patient outcomes.
Guidance to save patient function when treatment is not necessary.
Guidance based on new ideas and innovative concepts not available in current diagnostics.
Guidance to minimize invasive testing and side effects.
Guidance where currently there is no accurate way to determine whether aggressive treatment is required or not.
Guidance to improve patient outcomes.
Guidance to save patient function when treatment is not necessary.
Guidance based on new ideas and innovative concepts not available in current diagnostics.